Criteria for use (April 2018 P&T) - Reserve use of cisatracurium for patients with renal and hepatic dysfunction since these patients may experience increased plasma concentrations of parent compound and active metabolite of vecuronium.

• Micromedex Drug Information
• Micromedex Care Notes
• Drugs@FDA
• FDA Daily Med Package Inserts